PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
74.27%
Net income growth under 50% of CSIQ's 158.41%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-176.22%
Negative yoy D&A while CSIQ is 0.00%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-24.54%
Negative yoy working capital usage while CSIQ is 36.36%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-370.67%
Negative yoy inventory while CSIQ is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
-2.54%
Negative yoy usage while CSIQ is 36.36%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
92.83%
Well above CSIQ's 126.30%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-12.55%
Negative yoy CFO while CSIQ is 171.37%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-23.34%
Both yoy lines negative, with CSIQ at -1.91%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-22.75%
We reduce yoy invests while CSIQ stands at 4.41%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-103.31%
We cut debt repayment yoy while CSIQ is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
1365300.00%
Issuance growth of 1365300.00% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
No Data
No Data available this quarter, please select a different quarter.